United States Anhydrous Dibasic Calcium Phosphate Market Insight
Published: 27 May 2026 | Report Format: Electronic (PDF)
The anhydrous dibasic calcium phosphate market in the United States is estimated to record a CAGR of around 5.88% till 2035, fueled by rising consumption for pharmaceutical preparations, supplements, food fortification, and high-end animal nutrition formulations.
U.S. Anhydrous Dibasic Calcium Phosphate Market Insights Forecasts to 2035
- The US Anhydrous Dibasic Calcium Phosphate Market Size Was Estimated at USD 412 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 5.88% from 2025 to 2035
- The US Anhydrous Dibasic Calcium Phosphate Market Size is Expected to Reach USD 729 Million by 2035
Notable Insights for U.S. Anhydrous Dibasic Calcium Phosphate Market
- By application, pharmaceutical excipients accounted for nearly 41.6% share of the United States anhydrous dibasic calcium phosphate market in 2025.
- The United States government invested more than USD 8.9 Billion between 2024 and 2026 toward pharmaceutical manufacturing expansion, nutraceutical production infrastructure, food fortification initiatives, and specialty mineral processing technologies, significantly supporting demand for anhydrous dibasic calcium phosphate across healthcare and food industries.
- According to estimates published by the United States Food and Drug Administration, the U.S. dietary supplements industry witnessed approximately 9.7% growth in product registrations during 2025, while The United States represented nearly 34% of North America’s specialty pharmaceutical excipient and food-grade calcium phosphate production capacity in 2025, reinforcing the country’s strategic position within the global specialty minerals and healthcare ingredients industry.utilization of calcium-based mineral ingredients across nutraceutical and pharmaceutical applications increased by nearly 11.4%.
Download the eBook (ToC)
- The United States represented nearly 34% of North America’s specialty pharmaceutical excipient and food-grade calcium phosphate production capacity in 2025, reinforcing the country’s strategic position within the global specialty minerals and healthcare ingredients industry.
What Makes Decisions Advisors Research Unique?
- Specialty Chemical Intelligence and Nutraceutical Industry Forecasting
Decisions Advisors delivers specialized market intelligence through comprehensive evaluation of pharmaceutical excipient demand, nutraceutical ingredient trends, mineral fortification technologies, specialty chemical manufacturing developments, and healthcare ingredient supply chain dynamics.
- Advanced Chemical Industry Research Methodology and Regulatory Validation
Our analytical methodology integrates pharmaceutical manufacturer interviews, FDA regulatory assessments, specialty mineral production analysis, healthcare industry benchmarking, food ingredient demand evaluation, and secondary market validation to generate highly accurate market forecasts and strategic business intelligence.
- Pharmaceutical Mineral Technology Benchmarking and Competitive Landscape Analysis
The study provides comprehensive analysis of pharmaceutical-grade calcium phosphate technologies, mineral purification processes, functional food ingredient innovation, excipient manufacturing advancements, and nutraceutical formulation developments.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the US Anhydrous Dibasic Calcium Phosphate market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United States Anhydrous Dibasic Calcium Phosphate Market
- Innophos Holdings Inc.
- ICL Group Ltd.
- Prayon S.A.
- Budenheim USA Inc.
- Chemische Fabrik Budenheim KG
- A.B. Enterprises
- Hindustan Phosphates Pvt. Ltd.
- Advance Inorganics
- Jost Chemical Co.
- Merck KGaA
- American Elements
- Others
Recent Developments:
- In March 2026, Innophos Holdings Inc. announced an investment exceeding USD 145 Million toward the expansion of specialty phosphate ingredient manufacturing capabilities across North America, supporting increased pharmaceutical excipient production and advanced nutritional ingredient development.
- In September 2025, Budenheim USA Inc. introduced high-purity anhydrous dibasic calcium phosphate solutions designed for pharmaceutical tablet compression and nutraceutical applications, improving formulation stability and mineral bioavailability by approximately 13% across selected healthcare product lines.
Market Segmentation:
United States Anhydrous Dibasic Calcium Phosphate Market, By Grade
- Pharmaceutical Grade
- Food Grade
- Feed Grade
- Industrial Grade
United States Anhydrous Dibasic Calcium Phosphate Market, By Application
- Pharmaceutical Excipients
- Dietary Supplements
- Food Fortification
- Animal Feed
- Chemical Processing
- Others
United States Anhydrous Dibasic Calcium Phosphate Market, By End User
- Pharmaceutical Companies
- Food & Beverage Manufacturers
- Nutraceutical Companies
- Animal Nutrition Producers
- Chemical Manufacturers
Expert Views:
As per analysts in the field of specialty chemicals and the healthcare industry, the United States market for anhydrous dibasic calcium phosphate is projected to display stable growth prospects in the long run on account of growing pharmaceutical manufacturing operations, enhanced intake of fortified nutritional products, and increased usage of high-purity mineral excipients within the healthcare sector.
Author: Govind and Krishna By Spherical Insights and Consulting